Robbins LLP logo white Background.png
BNTX INVESTOR NEWS: Shareholders Should Contact Robbins LLP for Information About the Securities Fraud Class Action Against BioNTech SE
06 févr. 2024 00h36 HE | Robbins LLP
BioNTech SE (BNTX) Allegedly Misled Investors Regarding its Business Prospects
Robbins LLP logo white Background.png
EVVTY Class Action Alert: Robbins LLP Reminds Investors of Evolution AB (publ) Class Action
01 févr. 2024 17h50 HE | Robbins LLP
Evolution AB (EVVTY) Misled Investors Regarding its Business Prospects
Robbins LLP logo white Background.png
AlloVir, Inc. (ALVR) Stockholder News: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in AlloVir, Inc. Class Action
29 janv. 2024 19h45 HE | Robbins LLP
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies
Robbins LLP logo white Background.png
BioVie Inc. (BIVI) Stockholder News: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in BioVie Inc. Class Action
29 janv. 2024 19h27 HE | Robbins LLP
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial
Robbins LLP logo white Background.png
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Evolution AB (publ) (EVVTY)
24 janv. 2024 20h25 HE | Robbins LLP
Evolution AB (EVVTY) Misled Investors Regarding its Business Prospects
Robbins LLP logo white Background.png
ASRT Class Action Alert: Stockholders with Significant Losses in Assertion Holdings, Inc. Should Contact Robbins LLP for Information About the Class Action Lawsuit Against the Company
24 janv. 2024 20h23 HE | Robbins LLP
Assertio Holdings, Inc. (ASRT) Allegedly Misled Investors Regarding its Reliance on Indocin and Integration of Spectrum Pharmaceuticals, Inc.
Robbins LLP logo white Background.png
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against BioVie Inc. (BIVI)  
23 janv. 2024 15h24 HE | Robbins LLP
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial
Robbins LLP logo white Background.png
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against AlloVir, Inc. (ALVR)
22 janv. 2024 21h09 HE | Robbins LLP
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies
Robbins LLP logo white Background.png
Dada Nexus Limited (DADA) Investor Alert: Robbins LLP Reminds Shareholders of Class Action Against Dada Nexus Limited
22 janv. 2024 17h59 HE | Robbins LLP
Dada Nexus Limited (DADA) Allegedly Overstated its Revenues
Robbins LLP logo white Background.png
Robbins LLP Reminds Fisker Inc. Investors of Pending Lead Plaintiff Deadline in FSR Class Action
10 janv. 2024 14h12 HE | Robbins LLP
Fisker Inc. (FSR) Failed to Disclose a Material Weakness in Internal Control Over Financial Reporting